Back

AskBio completes GenePHIT enrollment with more than 170 heart-failure participants

Verifying
  • AskBio announced completed enrollment and randomization in the GenePHIT heart-failure trial.
  • More than 170 participants were randomized across 64 sites in 12 countries.
  • GenePHIT baseline characteristics were presented at the ESC Congress in August 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.